Two Sigma Investments
LPCN icon

Two Sigma Investments’s Lipocine LPCN Stock Holding History

Two Sigma Investments’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$270K Buy
+33,750
New +$294K ﹤0.01% 4136
2023
Q3 		– Sell
-11,033
Closed -$55.6K – 3100
2023
Q2 		$55.6K Sell
11,033
-3,907
-26% -$18.4K ﹤0.01% 2815
2023
Q1 		$80.8K Sell
14,940
-2,077
-12% -$16K ﹤0.01% 2700
2022
Q4 		$115K Sell
17,017
-2,110
-11% -$15.4K ﹤0.01% 2490
2022
Q3 		$146K Sell
19,127
-7,854
-29% -$87.7K ﹤0.01% 2176
2022
Q2 		$367K Buy
26,981
+5,800
+27% +$90.4K ﹤0.01% 1945
2022
Q1 		$493K Buy
21,181
+15,146
+251% +$317K ﹤0.01% 2021
2021
Q4 		$102K Buy
+6,035
New +$112K ﹤0.01% 4054
2020
Q3 		– Sell
-5,700
Closed -$122K – 3350
2020
Q2 		$122K Buy
+5,700
New +$73.9K ﹤0.01% 2764
2019
Q2 		– Sell
-860
Closed -$34K – 3512
2019
Q1 		$34K Buy
+860
New +$26.4K ﹤0.01% 2951

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Two Sigma Investments's LPCN Position: Q1 2026 in Review

Two Sigma Investments opened a new position in Lipocine (LPCN) in Q1 2026: 33,750 shares worth $270K. The stake represents ﹤0.01% of the portfolio and ranks #4136 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in LPCN as recently as Q2 2023.

Two Sigma Investments first reported a position in LPCN in Q1 2019 and has held it in 10 quarters since. The position peaked at $493K in Q1 2022. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Two Sigma Investments held 33,750 shares of Lipocine worth $270K as of Q1 2026.
  • Lipocine was a new Two Sigma Investments position in Q1 2026.
  • Lipocine made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4136 holding.
  • Two Sigma Investments first reported a position in Lipocine in Q1 2019 and has held it in 10 quarters since.
  • Two Sigma Investments's Lipocine position peaked at $493K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.